
    
      1. To evaluate bleeding risk in interventional procedures in patients with or without
           antiplatelet and/or anticoagulant therapy.

        2. To evaluate differences in outcomes in patients not receiving any anticoagulant or
           antiplatelet therapy compared to patients receiving various types of drugs with
           anticoagulant or antiplatelet therapeutic effects.

        3. To evaluate and compare the adverse event profiling all patients.
    
  